236 related articles for article (PubMed ID: 6280485)
1. Acute hypotensive and renin-stimulating actions of captopril before and during treatment with a beta-blocking drug.
Leonetti G; Biachini C; Terzoli L; Gradnik R; Tusa M; Bramati E; Zanchetti A
Am J Cardiol; 1982 Apr; 49(6):1564-5. PubMed ID: 6280485
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
[TBL] [Abstract][Full Text] [Related]
3. Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension.
Seedat YK
S Afr Med J; 1979 Dec; 56(23):983-6. PubMed ID: 399093
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
Am Heart J; 1983 Aug; 106(2):321-8. PubMed ID: 6346849
[TBL] [Abstract][Full Text] [Related]
5. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
[TBL] [Abstract][Full Text] [Related]
6. The hypotensive effect of propranolol in captopril-treated patients does not involve the plasma renin--angiotensin--aldosterone system.
Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():441s-444s. PubMed ID: 7032826
[TBL] [Abstract][Full Text] [Related]
7. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
Sassano P; Pedrinelli R; Magagna A; Abdel-Haq B; Salvetti A
Am J Cardiol; 1982 Apr; 49(6):1574-6. PubMed ID: 6280486
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.
Stumpe KO; Overlack A; Kolloch R; Schreyer S
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):121S-126S. PubMed ID: 6291563
[TBL] [Abstract][Full Text] [Related]
9. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
[TBL] [Abstract][Full Text] [Related]
10. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
[TBL] [Abstract][Full Text] [Related]
11. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise.
Pickering TG; Case DB; Sullivan PA; Laragh JH
Am J Cardiol; 1982 Apr; 49(6):1566-8. PubMed ID: 7041599
[TBL] [Abstract][Full Text] [Related]
13. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
14. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
Vandenburg MJ; Holly JM; Goodwin FJ; Sharman VL; Marsh FP
Eur J Clin Pharmacol; 1983; 25(6):721-8. PubMed ID: 6319152
[TBL] [Abstract][Full Text] [Related]
15. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.
Weinberger MH
Am J Cardiol; 1982 Apr; 49(6):1542-3. PubMed ID: 7041594
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
17. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
18. Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.
Ferguson RK; Vlasses PH; Koffer H; Clementi RA; Koplin JR; Willcox CM
Pharmacotherapy; 1983; 3(2 Pt 1):125-30. PubMed ID: 6344035
[TBL] [Abstract][Full Text] [Related]
19. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
20. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
Waeber B; Gavras I; Brunner HR; Cook CA; Charocopos F; Gavras HP
Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
